Novel serum biomarkers for infection in paediatric emergency

M. Petrisano, F.B. Mercuri, S. Sestito, A.A. Crispino, M. Miraglia Del, F. Borgia, R. De Sarro, L. Oreto, C. Cuppari, A. Salpietro, E. Murone, L. Pensabene, D. Concolino

Article ID: 4976
Vol 36, Issue 1S1, 2022
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.202236.1S1.18
Received: 11 March 2022; Accepted: 11 March 2022; Available online: 11 March 2022; Issue release: 11 March 2022

Abstract

Sepsis is one of the most frequent causes of morbidity and mortality in the paediatric age, and its early recognition is important to prevent its lethal outcomes. A great variety of novel serum biomarkers of infection have been investigated in the last decades, although most of the research has been performed in adult patients. We report current knowledge on this topic to assess the diagnostic efficacy of novel biomarkers of infection in paediatric patients.


Keywords

infection;biomarkers;children;sepsis;pediatric;novel biomarkers


References

Supporting Agencies



Copyright (c) 2022 M. Petrisano, F.B. Mercuri, S. Sestito, A.A. Crispino, M. Miraglia Del Giudice, F. Borgia, R. De Sarro, L. Oreto, C. Cuppari, A. Salpietro, E. Murone, L. Pensabene, D. Concolino




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).